Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

392
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
392
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

430
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
430
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

573
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
573
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

634
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
634
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

459
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
459
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

506
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
506

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Outcomes of Standard Permanent Active Fixation Leads for Temporary Pacing.

JACC. Clinical electrophysiology·2020
Same author

Outcomes of subcutaneous implantable cardioverter-defibrillator implantation in patients on hemodialysis.

Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing·2016
Same author

Aggregatibacter aphrophilus pacemaker endocarditis: a case report.

BMC research notes·2014
Same author

Should all patients with acute pericarditis be treated with colchicine?

Cleveland Clinic journal of medicine·2007
Same author

Direct thrombin inhibitors: stroke prevention in atrial fibrillation and potential anti-inflammatory properties.

American heart journal·2005
Same author

Recognition of apertures in overhead transparent barriers by leopard frogs.

Brain, behavior and evolution·2004

Related Experiment Video

Updated: Feb 22, 2026

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction
09:20

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction

Published on: February 13, 2021

7.1K

Device Management in Heart Failure.

Brett G Angel1, Heath Saltzman2, Luke S Kusmirek2

  • 1Division of Cardiology, Hahnemann University Hospital, Drexel University College of Medicine, 245 North 15th Street, Suite 6122, Philadelphia, PA, 19102, USA. bga26@drexel.edu.

Current Cardiology Reports
|September 27, 2017
PubMed
Summary

Implantable devices like internal cardioverter defibrillators (ICDs) and cardiac resynchronization therapy (CRT) improve heart failure management. These technologies enhance patient prognosis beyond optimal medical therapy alone.

Keywords:
Cardiac resynchronization therapy (CRT)DyssynchronyInternal cardioverter defibrillator (ICD)Left bundle branch block (LBBB)Sudden cardiac death (SCD)Systolic heart failureVentricular tachycardia and fibrillation

More Related Videos

Author Spotlight: Workflow for Integrating POCUS Data into EHR for Managing Heart Failure Patients
03:47

Author Spotlight: Workflow for Integrating POCUS Data into EHR for Managing Heart Failure Patients

Published on: July 12, 2024

1.2K
Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart
08:49

Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart

Published on: May 11, 2018

10.0K

Related Experiment Videos

Last Updated: Feb 22, 2026

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction
09:20

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction

Published on: February 13, 2021

7.1K
Author Spotlight: Workflow for Integrating POCUS Data into EHR for Managing Heart Failure Patients
03:47

Author Spotlight: Workflow for Integrating POCUS Data into EHR for Managing Heart Failure Patients

Published on: July 12, 2024

1.2K
Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart
08:49

Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart

Published on: May 11, 2018

10.0K

Area of Science:

  • Cardiology
  • Biomedical Engineering
  • Medical Devices

Background:

  • Medical devices are crucial for heart failure management.
  • Not all patients benefit from every device, and guidelines are evolving.
  • Implantable devices complement medical therapy and impact prognosis.

Purpose of the Study:

  • Summarize evolving literature on device guidelines for heart failure.
  • Review current and future implantable device technologies.
  • Highlight the impact of devices on heart failure management.

Main Methods:

  • Literature review of existing device guidelines.
  • Analysis of clinical trial data for implantable devices.
  • Exploration of novel pacing and defibrillator technologies.

Main Results:

  • Internal cardioverter defibrillators (ICDs) and cardiac resynchronization therapy (CRT) improve outcomes.
  • Devices save lives and reduce hospitalizations in heart failure patients.
  • Implantable devices offer benefits beyond guideline-directed medical therapy.

Conclusions:

  • Implantable devices are essential in comprehensive heart failure care.
  • Ongoing research and technological advancements continue to refine device therapy.
  • Devices significantly enhance the management and prognosis of heart failure.